New treatment for common digestive condition Barrett’s Oesophagus

New research from the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust could transform treatments and diagnosis for a common digestive condition which affects thousands of patients.

The oesophagus or food pipe (gullet) is part of the digestive system. It is the tube that carries food from your mouth to your stomach. Barrett’s Oesophagus (also known as BE) and low-grade dysplasia affects approximately 2% of the adult population, particularly those with heartburn, as acid reflux from the stomach can, over time, damage the lining of the oesophagus and lead to BE. BE is seen in people undergoing endoscopy to determine the cause of their digestive problems. Barrett’s Oesophagus can sometimes lead to cancer.

The team of researchers from Warwick Medical School, UHCW NHS Trust and Coventry University’s Centre for Technology Enabled Health Research found that invasive procedures are often not the best option to treat and diagnose patients suffering from Barrett’s Oesophagus.

Publishing their findings in the American Journal of Gastroenterology, the researchers looked at a wide range of studies about this condition.

Patients are currently commonly offered surgery for pre-cancerous changes in BE. However, the researchers found that in most cases, medical therapies and continuous monitoring are more effective to identify and prevent cancer for patients than surgery.

Where patients had a more advanced form of the condition, however, the team found that endoscopic resection surgery was the best option.

Barrett’s Oesophagus

Barrett’s Oesophagus is a condition in which the oesophagus changes, so that some of its lining is replaced by a type of tissue similar to that normally found in the intestine. This lining is called intestinal metaplasia. Barrett’s Oesophagus is closely associated with Gastro-Oesophageal Reflux Disease (GORD), in which food and gastric liquids can enter the oesophagus from the stomach. It is presumed that the recurrent entry of these liquids into the oesophagus lead to the change of the oesophageal lining into that of intestinal Metaplasia.

While Barrett’s Oesophagus may cause no symptoms itself, a small number of people with this condition develop a relatively rare but often deadly type of cancer of the oesophagus called Oesophageal Adenocarcinoma. This condition was described in the early 1950’s by an Australian Surgeon Dr. Norman Rupert Barrett, who noticed that cells lining and extending from the lower oesophagus were secreting red mucus without causing inflammation. He believed these cells made up a tubular stomach in patient’s who had a short oesophagus, however ten years later he discovered that the mucus secreting cells were an abnormality of normal cells, which now is known to lead to oesophageal cancer. Hence this condition is named in honour of Dr. Barrett.

New treatment for common digestive condition Barrett's Oesophagus The team also recommended that men over 60 who had suffered gastro-oesophageal reflux disease (GORD) for ten years or over should be screened for Barrett’s Oesophagus.

The researchers have developed a new definition of BE to standardise diagnosis of the condition for clinicians in the USA and Europe. The team has also proposed a clear plan for treating patients depending on how their condition develops.

The world-leading study is believed to be one of the largest reviews of this kind in internal medicine. The team reviewed 20,300 papers by over 100 world experts.

Professor Janusz Jankowski, Professor of Acute Medicine at Warwick Medical School and UHCW NHS Trust, said: “This paper could have huge implications for the thousands of patients diagnosed with Barrett’s Oesophagus. We hope that our findings will transform care for patients, and also help to identify patients at risk of developing cancer at the earliest possible opportunity.”

Barrett’s Oesophagus Causes and Symptoms

The exact causes of Barrett’s Oesophagus are unknown, but it is thought to be caused in part by the same factors that cause GORD. Although people who do not have heartburn can have Barrett’s Oesophagus, it is found about three to five times more often in people with this condition. Indeed 10-20% of people with chronic GORD will develop Barrett’s Oesophagus.

The muscular layers of the oesophagus are normally pinched together at both the upper and lower ends by muscles called sphincters. When a person swallows, the sphincters relax automatically to allow food or drink to pass from the mouth and into the stomach. The muscles then close rapidly to prevent the swallowed food or drink from leaking out of the stomach back into the oesophagus or into the mouth. These muscles make it possible to swallow while lying down or even upside-down. When people belch to release swallowed air or gas from carbonated beverages, the sphincters relax and small amounts of food or drink may come back up briefly; this condition is called reflux. The oesophagus quickly squeezes the material back into the stomach, and this is considered normal.

When a person experiences this regularly, especially when not trying to belch, then it is considered a medical problem or disease. The stomach produces acid and enzymes and when this mixture refluxes into the oesophagus frequently, it may produce symptoms. These symptoms, often called acid reflux, are usually described by people as heartburn, indigestion or “gas”. The symptoms usually consist of a burning sensation below and behind part of the breastbone or sternum. Most people have experienced these symptoms at least once, typically as a result of overeating. Other situations that provoke GORD symptoms include obesity, eating certain types of food and pregnancy. In most people, GORD symptoms may last only a short time and require no treatment. However, the more persistent and numerous these symptoms become, it is recommended that the person consult their doctor. These symptoms, if continuing for some time without relief from ‘over-the-counter’ ant-acid agents, can contribute to the development of GORD and eventually Barrett’s Oesophagus.

The average age of patients diagnosed with Barrett’s Oesophagus is 60; diagnosis of this condition diminishes the younger the person is, as Barrett’s develops over a longer time than GORD. Indeed it is uncommon for Barrett’s to be diagnosed in children. It is about twice as common in men as in women, and much more common in white men than in men of other racial background.

Professor Cathy Bennett, Professor in Systematic Reviews, at Coventry University, said: “We created a unique opportunity for doctors and scientists from around the world to work together. We used a specially designed web-based platform to interact, discuss and summarise the vast amount of medical evidence available for the management of this condition.

“As a result of our work, healthcare professionals from all parts of the world will be able to access these new key recommendations”

The group now plans to look at genetic markers for BE patients, to determine the risk of patients going on to develop cancer.

###

Notes to editors

The full paper, ‘BOB CAT, a Large-scale Review and Delphi Consensus for Management of Barrett’s Esophagus with No Dysplasia, Indefinite for, or Low Grade Dysplasia’, is available here: http://www.nature.com/ajg/journal/vaop/ncurrent/full/ajg201555a.html

About Barrett’s Oesophagus

Barrett’s Oesophagus is a common condition affecting the digestive system, which is commonly linked to long-term gastro-oesophageal reflux disease (GORD).

The average age at diagnosis is 62, and it is a pre-cancerous condition, meaning that a small number of patients go on to develop oesophageal cancer.

###

Kelly Parkes-Harrison
.(JavaScript must be enabled to view this email address)
0247-615-0868

University of Warwick

Journal
  American Journal of Gastroenterology

Provided by ArmMed Media